» Articles » PMID: 11356863

Dopamine D4 Receptor-deficient Mice Display Cortical Hyperexcitability

Overview
Journal J Neurosci
Specialty Neurology
Date 2001 May 23
PMID 11356863
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

The dopamine D(4) receptor (D(4)R) is predominantly expressed in the frontal cortex (FC), a brain region that receives dense input from midbrain dopamine (DA) neurons and is associated with cognitive and emotional processes. However, the physiological significance of this dopamine receptor subtype has been difficult to explore because of the slow development of D(4)R agonists and antagonists the selectivity and efficacy of which have been rigorously demonstrated in vivo. We have attempted to overcome this limitation by taking a multidimensional approach to the characterization of mice completely deficient in this receptor subtype. Electrophysiological current and voltage-clamp recordings were performed in cortical pyramidal neurons from wild-type and D(4)R-deficient mice. The frequency of spontaneous synaptic activity and the frequency and duration of paroxysmal discharges induced by epileptogenic agents were increased in mutant mice. Enhanced synaptic activity was also observed in brain slices of wild-type mice incubated in the presence of the selective D(4)R antagonist PNU-101387G. Consistent with greater electrophysiological activity, nerve terminal glutamate density associated with asymmetrical synaptic contacts within layer VI of the motor cortex was reduced in mutant neurons. Taken together, these results suggest that the D(4)R can function as an inhibitory modulator of glutamate activity in the FC.

Citing Articles

Dopaminergic Modulation of Prefrontal Cortex Inhibition.

Di Domenico D, Mapelli L Biomedicines. 2023; 11(5).

PMID: 37238947 PMC: 10215621. DOI: 10.3390/biomedicines11051276.


Functional and pharmacological role of the dopamine D receptor and its polymorphic variants.

Ferre S, Belcher A, Bonaventura J, Quiroz C, Sanchez-Soto M, Casado-Anguera V Front Endocrinol (Lausanne). 2022; 13:1014678.

PMID: 36267569 PMC: 9578002. DOI: 10.3389/fendo.2022.1014678.


Underlying Susceptibility to Eating Disorders and Drug Abuse: Genetic and Pharmacological Aspects of Dopamine D4 Receptors.

Botticelli L, Micioni Di Bonaventura E, Del Bello F, Giorgioni G, Piergentili A, Romano A Nutrients. 2020; 12(8).

PMID: 32751662 PMC: 7468707. DOI: 10.3390/nu12082288.


The use of laser capture microdissection to identify specific pathways and mechanisms involved in impulsive choice in rats.

Meda S, Freund N, Norman K, Thompson B, Sonntag K, Andersen S Heliyon. 2019; 5(8):e02254.

PMID: 31485508 PMC: 6716106. DOI: 10.1016/j.heliyon.2019.e02254.


HPO-Shuffle: an associated gene prioritization strategy and its application in drug repurposing for the treatment of canine epilepsy.

Wang S, Meng X, Wang Y, Liu Y, Xia J Biosci Rep. 2019; 39(9).

PMID: 31427480 PMC: 6732366. DOI: 10.1042/BSR20191247.


References
1.
Cepeda C, Radisavljevic Z, Peacock W, Levine M, BUCHWALD N . Differential modulation by dopamine of responses evoked by excitatory amino acids in human cortex. Synapse. 1992; 11(4):330-41. DOI: 10.1002/syn.890110408. View

2.
Castellanos F, Giedd J, Marsh W, Hamburger S, Vaituzis A, Dickstein D . Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry. 1996; 53(7):607-16. DOI: 10.1001/archpsyc.1996.01830070053009. View

3.
Werner P, Hussy N, Buell G, Jones K, North R . D2, D3, and D4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes. Mol Pharmacol. 1996; 49(4):656-61. View

4.
Gillis J, Gilger J, Pennington B, DeFries J . Attention deficit disorder in reading-disabled twins: evidence for a genetic etiology. J Abnorm Child Psychol. 1992; 20(3):303-15. DOI: 10.1007/BF00916694. View

5.
LaHoste G, Swanson J, Wigal S, Glabe C, Wigal T, King N . Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry. 1996; 1(2):121-4. View